|
TGS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.04089999636892E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88869999639962E-08 |
| Normal-vs-Stage2 |
2.482400E-02 |
| Normal-vs-Stage3 |
9.782200E-03 |
| Normal-vs-Stage4 |
3.185400E-01 |
| Stage1-vs-Stage2 |
2.936400E-01 |
| Stage1-vs-Stage3 |
5.284100E-02 |
| Stage1-vs-Stage4 |
1.608280E-02 |
| Stage2-vs-Stage3 |
8.781000E-01 |
| Stage2-vs-Stage4 |
4.081800E-01 |
| Stage3-vs-Stage4 |
3.596600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47120002239143E-09 |
| Normal-vs-AfricanAmerican |
7.432700E-04 |
| Normal-vs-Asian |
1.198440E-01 |
| Caucasian-vs-AfricanAmerican |
2.059400E-01 |
| Caucasian-vs-Asian |
3.632400E-01 |
| AfricanAmerican-vs-Asian |
7.881800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29050120484453E-11 |
| Normal-vs-Female |
1.613970E-02 |
| Male-vs-Female |
5.594600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.005700E-04 |
| Normal-vs-Extreme_Weight |
1.85220000004094E-07 |
| Normal-vs-Obese |
1.459230E-03 |
| Normal-vs-Extreme_Obese |
9.80149999999513E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.763220E-01 |
| Normal_Weight-vs-Obese |
3.725800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.733800E-02 |
| Extreme_Weight-vs-Obese |
7.540200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.717400E-01 |
| Obese-vs-Extreme_Obese |
8.744700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.404600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.51360000000267E-06 |
| Normal-vs-Age(61-80Yrs) |
2.63690003166062E-09 |
| Normal-vs-Age(81-100Yrs) |
1.40629999978437E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.535800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.184370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.686500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.598100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.529700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82880044441447E-10 |
| Normal-VS-Type2 PRCC |
1.89320000010262E-07 |
| Normal-VS-KIRP CIMP |
3.826000E-02 |
| Normal-VS-Unclassified PRCC |
1.618790E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.284600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.638840E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.072800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.176700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.290400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.277000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.46939999851648E-08 |
| Normal-vs-N1 |
3.441400E-01 |
| Normal-vs-N2 |
6.624000E-01 |
| N0-vs-N1 |
1.284330E-03 |
| N0-vs-N2 |
3.143400E-01 |
| N1-vs-N2 |
9.717000E-01 |
|
|
